The present invention pertains to an oral care implement with a cleanser for cleaning soft tissue surfaces in the mouth.
According to the American Dental Association, a major source of bad breath in healthy people is microbial deposits on the tongue, where a bacterial coating harbors organisms and debris that contribute to bad breath. The tongue is a haven for the growth of microorganisms since the papillary nature of the tongue surface creates a unique ecological site that provides an extremely large surface area, favoring the accumulation of oral bacteria. Anaerobic flora and bacteria residing on the tongue play an important role in the development of chronic bad breath commonly called halitosis. In general, the bacteria produce volatile sulfur compounds (VSC). If there is enough buildup of the sulfur compounds, the result can be lead bad breath or oral malodor.
While bladed tongue scrapers have been used in the past, these scrapers are inadequate in respect to their effectiveness on the soft tissue surface of the tongue. Broad flat scraping blades are limited in their ability to reach between the papillae where the bacteria and microdebris have collected. Moreover, notwithstanding the benefits to be gained by any ability to clean the tongue, some users avoid the use of such blades because of lack of comfort on the tongue surface.
Hence, there is a need for an oral care implement with a tongue cleanser that provides effective removal of the tongue bacteria and other debris while maintaining comfort to the user.
The invention pertains to an oral care implement with a tissue cleanser that provides improved cleaning and effective removal of bacteria and microdebris disposed on the oral tissue surfaces.
In one aspect, the invention can be an oral care implement comprising: a head and a handle; a plurality of tooth cleaning elements extending from a first face of the head; a receiving cavity formed into a second face of the head opposite the first face; a soft tissue cleanser formed of an elastomeric material that is injection molded into the receiving cavity, the soft tissue cleanser comprising a plurality of projections; and one or more peg members extending from a lower base surface of the receiving cavity, the soft tissue cleanser comprising one or more complementary apertures that receive the one or more peg members and expose tops of the one or more peg members.
In another aspect, the invention can be an oral care implement comprising: a head and a handle; a plurality of tooth cleaning elements extending from a first face of the head; a receiving cavity formed into a second face of the head opposite the first face; and a soft tissue cleanser formed of an elastomeric material that is injection molded into the receiving cavity to bond the soft tissue cleanser to the head, the soft tissue cleanser comprising a plurality of projections extending beyond the second face of the head.
In yet another aspect, the invention can be an oral care implement comprising: a handle; a head having a longitudinal axis; a plurality of tooth cleaning elements extending from a first face of the head; a receiving cavity formed into a second face of the head opposite the first face, the receiving cavity comprising a peripheral sidewall extending away from a lower base surface; a soft tissue cleanser formed of an elastomeric material that is injection molded into the receiving cavity to bond the soft tissue cleanser to the head, the soft tissue cleanser comprising a plurality of nubs that extend beyond the second face of the head; and at least one peg member aligned along the longitudinal axis and extending from the lower base surface of the receiving cavity, the soft tissue cleanser comprising at least one complementary aperture that exposes a top of the at least one peg member.
In an even further aspect, the invention can be an oral care implement comprising: a head and a handle; a plurality of tooth cleaning elements extending from a first face of the head; a soft tissue cleanser on the head opposite the first face, the soft tissue cleanser formed of an elastomeric material that is injection molded to the head to bond the soft tissue cleanser to the head, the soft tissue cleanser comprising a plurality of projections; and at least one peg member aligned along the longitudinal axis and extending from the head, the soft tissue cleanser comprising at least one complementary aperture that exposes a top of the at least one peg member
Further areas of applicability of the present invention will become apparent from the detailed description provided hereinafter. It should be understood that the detailed description and specific examples, while indicating the preferred embodiment of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention.
A more complete understanding of the present invention and the advantages thereof may be acquired by referring to the following description in consideration of the accompanying drawings, in which like reference numbers indicate like features, and wherein:
The following description of the preferred embodiment(s) is merely exemplary in nature and is in no way intended to limit the invention, its application, or uses.
In the following description, the invention is discussed in terms of a toothbrush, but could be in the form of other oral care implements including simply a tissue cleansing implement. Further, it is to be understood that other embodiments may be utilized and structural and functional modifications may be made without departing from the scope of the present invention.
The elastomeric material of tissue cleanser 300 may be any biocompatible resilient material suitable for uses in an oral hygiene apparatus. To provide optimum comfort as well as cleaning benefits, the elastomeric material preferably has a hardness property in the range of A8 to A25 Shore hardness. As an example, one preferred elastomeric material is styrene-ethylene/butylene-styrene block copolymer (SEBS) manufactured by GLS Corporation. Nevertheless, SEBS material from other manufacturers or other materials within and outside the noted hardness range could be used.
Tissue cleanser 300 is preferably configured with a multiplicity of tissue engaging elements 303 (
Such tissue engaging elements 303 are designed to significantly reduce a major source of bad breath in people and improve hygiene. Nubs 303 enable removal of microflora and other debris from the tongue and other soft tissue surfaces within the mouth. The tongue, in particular, is prone to develop bacterial coatings that are known to harbor organisms and debris that can contribute to bad breath. This microflora can be found in the recesses between the papillae on most of the tongue's upper surface as well as along other soft tissue surfaces in the mouth. When engaged or otherwise pulled against a tongue surface, for example, nubs 303 of elastomeric tissue cleanser 300 provide for gentle engagement with the soft tissue while reaching downward into the recesses of adjacent papillae of the tongue. The elastomeric construction of tissue cleanser 300 also enables the base surface 301 to follow the natural contours of the oral tissue surfaces, such as the tongue, cheeks, lips, and gums of a user. Moreover, the soft nubs 303 are able to flex as needed to traverse and clean the soft tissue surfaces in the mouth along which it is moved.
As seen in
Alternatively, the tissue cleaning elements 303 may have other shapes. As one example, the tissue cleanser may have a grated form such as described in co-pending U.S. patent application Ser. No. 10/601,106, incorporated herein by reference.
In a preferred construction, nubs 303 are disposed on the base surface 301 of tissue cleanser 300 in a high density pattern. Each nub 303 is preferably spaced apart from adjacent nubs 303 between a range of about 0.5 mm to about 3 mm; more preferably the spacing ranges between 0.7 mm to 2.5 mm, and most preferably between 1 mm to 2 mm. Nevertheless, other spacing ranges are possible. The surface density of the nubs 303 on base surface 301 ranges preferably from about 100 to about 600 nubs per square inch. In a more preferred construction of the tissue cleanser, the surface density may range from 200 to 500 nubs per square inch, and most preferably between 300 to 450 nubs per square inch. In one preferred example, tissue cleanser 300 includes about 400 nubs per square inch of surface area. The surface density features in conjunction with the height of the nubs 303 enables the tissue cleanser to provide enhanced cleaning of the soft tissue surfaces with improved comfort. Nonetheless, other surface densities are possible.
As seen in
Tongue cleanser 300 is preferably formed by being molded to head 105, although other manufacturing processes could be used. With reference to
As can be seen in
Alternatively, basin 111 and peg members 117a-c may be provided to position and hold a previously molded tissue cleanser, although these constructions are not necessary to use such a previously molded tissue cleanser.
Peg members 117a-c may take on a variety of shapes and lengths. With continued reference to the
As shown in
In the preferred construction (
Referring to
As various changes could be made in the above methods, compositions and structures without departing from the scope of the invention, it is intended that all matter contained in this application, including all mechanisms and/or modes of interaction described above, shall be interpreted as illustrative only and not limiting in any way the scope of the appended claims.
The following examples are set forth as representative of the improved operation of the present invention. These examples are not to be construed as limiting the scope of the invention.
The performance nature of a toothbrush can be measured using known oral malodor assessment methods. A study was conducted to evaluate the performance of a toothbrush provided with an elastomeric tissue cleanser having conically shaped nubs, such as the preferred construction of toothbrush 100 discussed above. Human test subjects participated in the study. There was a washout or normalization period prior to testing of about 7 days in which the test subjects brushed twice a day with a fluoride dental cream (see Table 1). After the washout period, the test subjects were asked to refrain from any oral hygiene (brushing, rinsing, and flossing), eating and drinking prior to oral testing. A baseline volatile sulfur compound (VSC) sample was taken from each of the test subjects. In the study for overnight odor control, the test subjects brushed their teeth for one minute with a fluoride dental cream (see Table 1) using toothbrush 100 provided with the above noted tissue cleanser 300. Subsequently, the subjects cleaned their tongue surface with the tissue engaging elements of the toothbrush for ten seconds. The test subjects slept overnight and returned for post treatment. VSC samples were taken at the ten-hour time point from the previous day cleaning. In the illustrative example, use of the toothbrush reduced oral VSC about 60% versus brushing the teeth alone as measured from a baseline ten hours after use. The VSC readings were obtained by gas chromatography.
In another study of the above-noted toothbrush 100, there was a washout or normalization period prior to testing of about 7 days which the test subjects brushed twice a day with a fluoride dental cream (see Table 1). The test subjects were asked to refrain from any oral hygiene (brushing, rinsing, and flossing), eating and drinking before testing. After the washout period, the test subjects provided a baseline tongue bacteria sample by swabbing a side of the back of the tongue with a sterile cotton swab. The test subjects brushed their teeth with a fluoride dental cream (see Table 1) for one minute with the toothbrush having the above-noted tissue cleanser. Subsequently, the test subjects cleaned their tongue surface with a preferred construction of the tissue engaging elements 300 of the toothbrush 100 for ten seconds. Two hours after the cleaning of the tongue surface, a tongue bacteria sample was taken from a side of the back of the tongue with a cotton swab. In the illustrative example, use of the tissue engaging elements controlled more odor causing tongue bacteria than simply brushing the teeth alone. Use of the tissue cleanser 300 demonstrated a tongue bacteria log reduction of over 0.8 Log colony forming units/ml two hours after use on the tongue.
In another study of the above-noted toothbrush, a MTT assay was used to examine the viability of the epithelial cells collected from the oral cavity prior to and after the use of the toothbrush with the noted tissue cleanser. The MTT Assay was based on the enzymatic reduction of the tetrazolium salt MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide+++] in living, metabolically active cells. The reaction was carried out in situ in test tubes, and the reaction product, a purple-colored formazan soluble in dimethylsulfoxide, was measured colormetrically using a multiwell plate reader. Advantageously, the MTT Assay offers a high degree of precision, ease of use, and suitability for the purpose for large scale chemosensitivity testing.
Following a 7-day washout period, the test subjects reported to a test site without prior eating, drinking, or performing oral hygiene. The test subjects provided salivary rinse samples by rinsing their oral cavity with 9 ml of sterile water for 10 seconds and then discharging the water from the rinse into a tube containing 10* sterile phosphate buffered saline (PBS) solution. The samples were refrigerated for approximately 30 minutes before the MTT Assay was run. The test subjects brushed their teeth under supervision for one minute using a fluoride dental cream (see Table 1) followed by 10 seconds of tongue cleaning with the tongue cleanser 300 of the preferred construction. Approximately 30 minutes after brushing and tongue cleaning, the test subjects provided a rinse sample in the manner described previously.
The pre-rinse samples and post-rinse samples were centrifuged for 15 minutes at about 3000 RPM. The supernatant, e.g., clear liquid, was removed and the pellet was resuspended in 2.5 mL of PBS. The samples were vortexed for 5 seconds, then 2.5 ml of MTT Solution was added. The samples were subsequently incubated in a gently shaking waterbath set at 37[deg.] C. for 2 hours. Following the 2 hour incubation period, the samples were centrifuged for 15 minutes at about 3000 RPM. The supernatatant was siphoned out and 3 mL of detergent (0.04 N Acid Isopropanol) was added to dissolve purple crystals. An increase or decrease in MTT conversion was spectrophotometrically quantified. From each sample, 200 [mu]l of each was added to 96 well plates and the optical density was measured at 570 nm and compared to a negative buffer control. In the illustrative example, one minute of brushing followed by 10 seconds of use of the tissue cleanser reduced oral epithelial cells about 72% as determined by a MTT assay protocol.
In another study, human test subjects provided baseline VSC samples via a Halimeter™ (i.e., a sulfide meter). A Halimeter™ uses an electrochemical, voltammetric sensor which generates a signal when it is exposed to VSC such as, sulfide and mercaptan gases and measures the concentration of hydrogen sulfide gas in parts per billion. The test subjects brushed their teeth under supervision for one minute with the preferred construction of a toothbrush having the above noted tissue cleanser. Then, the test subjects used the noted toothbrush to provide six strokes on the tongue surface. A subsequent VSC sample was taken from the test subjects two hours after the brushing stage. In this illustrative example, use of a toothbrush with the tissue cleanser reduced the measured VSC in the mouth odor over 35% from a baseline measured two hours after use.
In one other study, after a washout period, human test subjects rinsed their mouths with sterile water to provide a baseline sample for viable epithelial cell analysis with the MTT assay. The subjects brushed their teeth under supervision for one minute with the preferred construction of the toothbrush having the above-noted tissue cleanser. Then, the test subjects used the tissue cleanser to provide six strokes on the tongue surface. The test subjects provided a post rinse sample for analysis. The samples were tested and analyzed in the manner as discussed with respect to Example 3. In this example, use of the toothbrush reduced oral epithelial cells by about 92% from a baseline as determined by MTT assay protocol.
In the above noted examples, the subjects brushed their teeth using a fluoride dental cream with the formulation in Table 1.
As used throughout, ranges are used as shorthand for describing each and every value that is within the range. Any value within the range can be selected as the terminus of the range. In addition, all references cited herein are hereby incorporated by referenced in their entireties. In the event of a conflict in a definition in the present disclosure and that of a cited reference, the present disclosure controls.
This application is a continuation application of U.S. patent application Ser. No. 13/116,735, filed May 26, 2011, now U.S. Pat. No. 8,522,386, which is a continuation of U.S. patent application Ser. No. 11/932,010, filed Oct. 31, 2007, now U.S. Pat. No. 7,950,100, which is a divisional application of U.S. patent application Ser. No. 11/566,479, filed Dec. 4, 2006, now U.S. Pat. No. 7,322,067, which is a divisional application of U.S. patent application Ser. No. 10/869,922, filed Jun. 18, 2004, now U.S. Pat. No. 7,143,462, which is: (1) a continuation-in-part of U.S. patent application Ser. No. 10/601,106, filed Jun. 20, 2003, abandoned; (2) a continuation-in-part of PCT patent application Ser. No. PCT/US03/030633 filed Sep. 26, 2003, which claims the benefit of priority to U.S. Provisional Application No. 60/414,117, filed Sep. 27, 2002, U.S. Provisional Application No. 60/418,776, filed Oct. 16, 2002 and U.S. patent application Ser. No. 60/419,425, filed Oct. 18, 2002; (3) a continuation-in-part of PCT Patent Application No. PCT/US2003/029497, filed Sep. 17, 2003, which claims the benefit of priority to U.S. Provisional patent application Ser. No. 60/412,290, filed Sep. 20, 2002; and (4) a continuation-in-part of U.S. patent application Ser. No. 29/189,729, filed Sep. 10, 2003, now U.S. Pat. No. D517,812. The contents of the above-noted applications are each expressly incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
411910 | Van Horne | Oct 1889 | A |
585358 | Gould | Jun 1897 | A |
697336 | Hagerty | Apr 1902 | A |
726727 | Mills | Apr 1903 | A |
864054 | Abrams | Aug 1907 | A |
907842 | Mauzies | Dec 1908 | A |
1002468 | Strangman | Sep 1911 | A |
1006630 | Clarke | Oct 1911 | A |
1125532 | Himmel | Jan 1915 | A |
1128139 | Hoffman | Feb 1915 | A |
1142698 | Crumbaugh | Jun 1915 | A |
1153409 | Wheeler | Sep 1915 | A |
1188823 | Plank | Jun 1916 | A |
1191556 | Blake | Jul 1916 | A |
1251250 | Libby | Dec 1917 | A |
1268544 | Cates | Jun 1918 | A |
1405279 | Cassedy | Jan 1922 | A |
1470710 | Davis | Oct 1923 | A |
1495675 | Colt | May 1924 | A |
1588785 | Van Sant | Jun 1926 | A |
1598224 | Van Sant | Aug 1926 | A |
1728956 | Damikzel | Sep 1927 | A |
1658706 | Carrott | Feb 1928 | A |
D75971 | Faubert et al. | Aug 1928 | S |
1704564 | Friedland | Mar 1929 | A |
1705109 | Essbach | Mar 1929 | A |
1741143 | Chin | Dec 1929 | A |
1816582 | Heron | Jul 1931 | A |
1817585 | Samuel | Aug 1931 | A |
1833555 | Bell et al. | Nov 1931 | A |
1860924 | Cooke | May 1932 | A |
1861347 | Johnson | May 1932 | A |
1872832 | Silverberg | Aug 1932 | A |
1891864 | Barrett | Dec 1932 | A |
1892068 | Metzler | Dec 1932 | A |
1903161 | Barkan | Mar 1933 | A |
1910414 | Varga | May 1933 | A |
1924152 | Coney et al. | Aug 1933 | A |
1993662 | Green | Mar 1935 | A |
1993763 | Touchstone | Mar 1935 | A |
D99352 | Grapp | Apr 1936 | S |
2042239 | Planding | May 1936 | A |
2049956 | Greenberg | Aug 1936 | A |
2059914 | Rosenberg | Nov 1936 | A |
2079728 | Arnold | May 1937 | A |
2083217 | Brothers et al. | Jun 1937 | A |
2088839 | Coney et al. | Aug 1937 | A |
2129082 | Byrer | Sep 1938 | A |
2161349 | Haddan | Jun 1939 | A |
2186005 | Casto | Jan 1940 | A |
2196284 | Ackerman | Apr 1940 | A |
D122815 | Crosby | Oct 1940 | S |
2218072 | Runnals | Oct 1940 | A |
2225331 | Campbell | Dec 1940 | A |
2233936 | Campbell | Mar 1941 | A |
2253210 | Psharls | Aug 1941 | A |
2253910 | Luenz | Aug 1941 | A |
2263802 | Grusin | Nov 1941 | A |
2305461 | Spyra | Dec 1942 | A |
2312828 | Adamsson | Mar 1943 | A |
2364205 | Fuller | Dec 1944 | A |
2405029 | Gallanty et al. | Jul 1946 | A |
2418485 | Shipley | Apr 1947 | A |
2443461 | Kempster | Jun 1948 | A |
2491274 | McNeill | Dec 1949 | A |
2512059 | Haeusser | Jun 1950 | A |
2543999 | Voss | Mar 1951 | A |
2545814 | Kempster | Mar 1951 | A |
D162941 | Ehman | Apr 1951 | S |
2554777 | Dangin | May 1951 | A |
2574654 | Moore | Nov 1951 | A |
2583750 | Runnals | Jan 1952 | A |
2637870 | Cohen | May 1953 | A |
2642604 | Ferrari | Jun 1953 | A |
2642804 | Ferral | Jun 1953 | A |
2651068 | Seko | Sep 1953 | A |
2686325 | Silver | Aug 1954 | A |
2702914 | Kittle et al. | Mar 1955 | A |
2708762 | Kling et al. | May 1955 | A |
3103680 | Krichmar | Sep 1963 | A |
3153800 | Trotin | Oct 1964 | A |
3181193 | Nobles et al. | May 1965 | A |
3185001 | Viator | May 1965 | A |
3195537 | Blasi | Jul 1965 | A |
3230562 | Birch | Jan 1966 | A |
3254356 | Yao et al. | Jun 1966 | A |
3258805 | Rossnan | Jul 1966 | A |
3261354 | Shpuntoff | Jul 1966 | A |
3337893 | Fine et al. | Aug 1967 | A |
D213669 | Miller | Apr 1969 | S |
3509874 | Stillman | May 1970 | A |
3610043 | Wenmyss | Oct 1971 | A |
3633237 | Bagube | Jan 1972 | A |
3638270 | Schlegel, Jr. et al. | Feb 1972 | A |
4249521 | Gueret | Feb 1981 | A |
4277862 | Weiderman | Jul 1981 | A |
4292705 | Stouffer | Oct 1981 | A |
4299208 | Blanc | Nov 1981 | A |
4328604 | Adams | May 1982 | A |
4356585 | Protell et al. | Nov 1982 | A |
4364142 | Pangle | Dec 1982 | A |
D272683 | Stocchi | Feb 1984 | S |
D272687 | Stocchi | Feb 1984 | S |
D272689 | Stocchi | Feb 1984 | S |
D272690 | Stocchi | Feb 1984 | S |
D273635 | Stocchi | May 1984 | S |
4455704 | Williams | Jun 1984 | A |
4461285 | Courtin | Jul 1984 | A |
4488327 | Snider | Dec 1984 | A |
4493125 | Collis | Jan 1985 | A |
4543679 | Rosofsky et al. | Oct 1985 | A |
4585416 | DeNiro et al. | Apr 1986 | A |
4592108 | Svendsen | Jun 1986 | A |
4607411 | Lews, Jr. | Aug 1986 | A |
4608968 | Rosofsky | Sep 1986 | A |
4610043 | Vezjak | Sep 1986 | A |
D287072 | Pfleger | Dec 1986 | S |
4628564 | Youssef | Dec 1986 | A |
D295695 | Golzari | May 1988 | S |
4827551 | Maser et al. | May 1989 | A |
4827557 | Siler, Jr. et al. | May 1989 | A |
4888844 | Maggs | Dec 1989 | A |
D309528 | Valenti | Jul 1990 | S |
5005246 | Yen-Hui | Apr 1991 | A |
5027796 | Linzey | Jul 1991 | A |
5032082 | Herrera | Jul 1991 | A |
5040260 | Michaels | Aug 1991 | A |
5120225 | Amit | Jun 1992 | A |
5165761 | Dirksing | Nov 1992 | A |
5176427 | Weihrauch | Jan 1993 | A |
5226197 | Nack et al. | Jul 1993 | A |
5230118 | Chamma | Jul 1993 | A |
5242235 | Li | Sep 1993 | A |
5249327 | Hing | Oct 1993 | A |
5273425 | Hoagland | Dec 1993 | A |
5305489 | Lage | Apr 1994 | A |
5339482 | Desimone et al. | Aug 1994 | A |
D350851 | Spence, Jr. | Sep 1994 | S |
5360026 | Klinkhammer | Nov 1994 | A |
5373600 | Stojanovski et al. | Dec 1994 | A |
5392483 | Heinzelman et al. | Feb 1995 | A |
5396678 | Bredall et al. | Mar 1995 | A |
5438726 | Leite | Aug 1995 | A |
5445825 | Copelan et al. | Aug 1995 | A |
5446940 | Curtis et al. | Sep 1995 | A |
5497526 | Klinkhammer | Mar 1996 | A |
5511273 | Carroll | Apr 1996 | A |
5530981 | Chen | Jul 1996 | A |
5535474 | Salazar | Jul 1996 | A |
5570487 | Schneider | Nov 1996 | A |
D376695 | Tveras | Dec 1996 | S |
5584690 | Maassarani | Dec 1996 | A |
5604951 | Shipp | Feb 1997 | A |
5613262 | Choy-Maldonado | Mar 1997 | A |
5628082 | Moskovich | May 1997 | A |
5673454 | Quintanilla et al. | Oct 1997 | A |
D386905 | Brady et al. | Dec 1997 | S |
5709004 | Paduano et al. | Jan 1998 | A |
D390706 | Hohlbein et al. | Feb 1998 | S |
D391769 | Kling et al. | Mar 1998 | S |
5729858 | Riffel | Mar 1998 | A |
5735011 | Asher | Apr 1998 | A |
5735012 | Heinzelman et al. | Apr 1998 | A |
5735864 | Heisinger, Jr. | Apr 1998 | A |
5758380 | Vrignaud | Jun 1998 | A |
5766193 | Millner | Jun 1998 | A |
D396288 | Samuel | Jul 1998 | S |
5778475 | Garcia | Jul 1998 | A |
5778476 | Squillaci et al. | Jul 1998 | A |
5779654 | Foley et al. | Jul 1998 | A |
5781958 | Meessmann et al. | Jul 1998 | A |
D397219 | Rangel et al. | Aug 1998 | S |
5792159 | Amin | Aug 1998 | A |
5802656 | Dawson et al. | Sep 1998 | A |
5809608 | Zadro | Sep 1998 | A |
5810856 | Tveras | Sep 1998 | A |
D399349 | Barth | Oct 1998 | S |
5817114 | Anderson et al. | Oct 1998 | A |
5818856 | Injeyan et al. | Oct 1998 | A |
D401069 | Lamond et al. | Nov 1998 | S |
D402116 | Magloff et al. | Dec 1998 | S |
5842247 | Decesare | Dec 1998 | A |
5845358 | Woloch | Dec 1998 | A |
D403510 | Menke et al. | Jan 1999 | S |
D404205 | Hohlbein | Jan 1999 | S |
D404206 | Hohlbein | Jan 1999 | S |
5860183 | Kam | Jan 1999 | A |
D405272 | Khalaj et al. | Feb 1999 | S |
D407221 | Van Gelder | Mar 1999 | S |
D407222 | Van Gelder | Mar 1999 | S |
D407223 | Van Gelder | Mar 1999 | S |
5875510 | Lamond et al. | Mar 1999 | A |
5896614 | Flewitt | Apr 1999 | A |
5913346 | Narwani | Jun 1999 | A |
5915433 | Hybler | Jun 1999 | A |
5920941 | Iannotta | Jul 1999 | A |
5926901 | Tseng et al. | Jul 1999 | A |
5928254 | Jensen | Jul 1999 | A |
5930860 | Shipp | Aug 1999 | A |
5930861 | White | Aug 1999 | A |
5938673 | DePierro et al. | Aug 1999 | A |
5945759 | Tanaka et al. | Aug 1999 | A |
5951578 | Jensen | Sep 1999 | A |
5957942 | Yudelman | Sep 1999 | A |
5967152 | Rimkus | Oct 1999 | A |
5970564 | Inns et al. | Oct 1999 | A |
5974614 | Ross | Nov 1999 | A |
5980541 | Tenzer | Nov 1999 | A |
5980542 | Saldivar | Nov 1999 | A |
5984935 | Welt et al. | Nov 1999 | A |
6015293 | Rimkus | Jan 2000 | A |
D420515 | Van Gelder | Feb 2000 | S |
6018840 | Guay et al. | Feb 2000 | A |
D421844 | Stark et al. | Mar 2000 | S |
6032315 | Liebel | Mar 2000 | A |
6041467 | Roberts et al. | Mar 2000 | A |
6041468 | Chen et al. | Mar 2000 | A |
D422413 | Goldinger et al. | Apr 2000 | S |
6049936 | Holley | Apr 2000 | A |
D423785 | Karallis | May 2000 | S |
D423786 | Zelinski | May 2000 | S |
D423787 | Musciano | May 2000 | S |
D424808 | Beals et al. | May 2000 | S |
D424809 | Bernard | May 2000 | S |
D425306 | Beals et al. | May 2000 | S |
6058541 | Masterman et al. | May 2000 | A |
D428702 | Van Gelder | Aug 2000 | S |
6098233 | Chen | Aug 2000 | A |
6105191 | Chen et al. | Aug 2000 | A |
6108851 | Bredall et al. | Aug 2000 | A |
6108869 | Meessmann et al. | Aug 2000 | A |
6119296 | Noe et al. | Sep 2000 | A |
6131228 | Chen et al. | Oct 2000 | A |
D434906 | Beals et al. | Dec 2000 | S |
6171323 | Potti et al. | Jan 2001 | B1 |
6205611 | Vigil | Mar 2001 | B1 |
D440767 | Moskovich et al. | Apr 2001 | S |
6254390 | Wagner | Jul 2001 | B1 |
6260227 | Fulop et al. | Jul 2001 | B1 |
6276021 | Hohlbein | Aug 2001 | B1 |
6289545 | Molster | Sep 2001 | B1 |
D448569 | Harris et al. | Oct 2001 | S |
6298516 | Beals et al. | Oct 2001 | B1 |
D450929 | Angelini et al. | Nov 2001 | S |
6311358 | Soeteway et al. | Nov 2001 | B1 |
6319332 | Gavney, Jr. et al. | Nov 2001 | B1 |
6322573 | Murayama | Nov 2001 | B1 |
6345405 | Brackin | Feb 2002 | B1 |
6352545 | Wagner | Mar 2002 | B1 |
6353958 | Weihrauch | Mar 2002 | B2 |
6360398 | Wiegner et al. | Mar 2002 | B1 |
RE37625 | Wieder et al. | Apr 2002 | E |
D456139 | Hohlbein | Apr 2002 | S |
6374448 | Seifert | Apr 2002 | B2 |
D456607 | Carlucci et al. | May 2002 | S |
6383202 | Rosenblood et al. | May 2002 | B1 |
6389634 | Devlin et al. | May 2002 | B1 |
D459087 | Pfleger | Jun 2002 | S |
6402768 | Liebel | Jun 2002 | B1 |
6408476 | Cann | Jun 2002 | B1 |
6408478 | Kazumura | Jun 2002 | B1 |
6421867 | Weihrauch | Jul 2002 | B1 |
D461959 | Chan et al. | Aug 2002 | S |
D463131 | Winter et al. | Sep 2002 | S |
6446295 | Calabrese | Sep 2002 | B1 |
D464796 | Winter et al. | Oct 2002 | S |
D464798 | Harada | Oct 2002 | S |
6463618 | Zimmer | Oct 2002 | B1 |
6463619 | Gavney, Jr. | Oct 2002 | B2 |
D465847 | Jacobs | Nov 2002 | S |
6496999 | Gleason et al. | Dec 2002 | B1 |
6513182 | Calabrese et al. | Feb 2003 | B1 |
D471276 | Potti | Mar 2003 | S |
6546586 | Cho | Apr 2003 | B2 |
D477465 | Reilly et al. | Jul 2003 | S |
D478211 | Ping | Aug 2003 | S |
6625839 | Fischer et al. | Sep 2003 | B2 |
D482199 | De Salvo | Nov 2003 | S |
6647581 | Persad et al. | Nov 2003 | B1 |
D483184 | Geiberger et al. | Dec 2003 | S |
D483568 | Jamson | Dec 2003 | S |
6658688 | Gavney, Jr. et al. | Dec 2003 | B2 |
D486649 | Sprosta et al. | Feb 2004 | S |
6729789 | Gordon | May 2004 | B2 |
6817054 | Moskovich et al. | Nov 2004 | B2 |
6859969 | Gavney et al. | Mar 2005 | B2 |
D503538 | Desalvo | Apr 2005 | S |
6886207 | Solanki | May 2005 | B1 |
6895629 | Wenzler | May 2005 | B1 |
20010023516 | Driesen et al. | Sep 2001 | A1 |
20010041903 | Richard | Nov 2001 | A1 |
20010042280 | Moskovich et al. | Nov 2001 | A1 |
20020004964 | Luchino et al. | Jan 2002 | A1 |
20020019645 | Fischer et al. | Feb 2002 | A1 |
20020108194 | Carlucci et al. | Aug 2002 | A1 |
20020124333 | Hafliger et al. | Sep 2002 | A1 |
20020124337 | Calabrese et al. | Sep 2002 | A1 |
20020138926 | Brown, Jr. et al. | Oct 2002 | A1 |
20020138928 | Calabrese | Oct 2002 | A1 |
20030009837 | Cann | Jan 2003 | A1 |
20030077107 | Kuo | Apr 2003 | A1 |
20030115699 | Wagstaff | Jun 2003 | A1 |
20030116884 | Wagstaff | Jun 2003 | A1 |
20030163149 | Heisinger et al. | Aug 2003 | A1 |
20030167582 | Fischer et al. | Sep 2003 | A1 |
20030196283 | Eliav | Oct 2003 | A1 |
20030208865 | Davies | Nov 2003 | A1 |
20030216762 | Levit | Nov 2003 | A1 |
20030229959 | Gavney, Jr. et al. | Dec 2003 | A1 |
20040006837 | Cann | Jan 2004 | A1 |
20040025275 | Moskovich et al. | Feb 2004 | A1 |
20040068810 | Lee | Apr 2004 | A1 |
20040134007 | Davies | Jul 2004 | A1 |
20040200748 | Klassen et al. | Oct 2004 | A1 |
20040255416 | Hohlbein | Dec 2004 | A1 |
20050000049 | Hohlbein | Jan 2005 | A1 |
20050069372 | Hohlbein et al. | Mar 2005 | A1 |
Number | Date | Country |
---|---|---|
99738 | Jun 1923 | CH |
ZL99225704.2 | Feb 1999 | CN |
99225704.2 | Jan 2000 | CN |
0857128 | Nov 1952 | DE |
2930459 | Feb 1981 | DE |
3114507 | Mar 1983 | DE |
3639424 | Jun 1988 | DE |
9416395 | Aug 1994 | DE |
0449655 | May 1995 | EP |
0875169 | Nov 1998 | EP |
1034721 | Sep 2000 | EP |
1308108 | May 2003 | EP |
1350442 | Oct 2003 | EP |
0537979 | Jun 1922 | FR |
2594307 | Aug 1987 | FR |
0017643 | Apr 1912 | GB |
0495982 | Nov 1938 | GB |
2371217 | Jul 2002 | GB |
2391462 | Feb 2004 | GB |
51 35303 | Aug 1976 | JP |
H08-047422 | Feb 1996 | JP |
9-182626 | Jul 1997 | JP |
10-42957 | Feb 1998 | JP |
2000308522 | Nov 2000 | JP |
2001-314232 | Nov 2001 | JP |
2000-278899 | Feb 2002 | JP |
2002-142857 | May 2002 | JP |
2002142867 | May 2002 | JP |
2002-223853 | Aug 2002 | JP |
1999-006098 | Feb 1999 | KR |
45152 | Feb 1939 | NL |
13155 | Mar 2000 | RU |
218988 | May 2002 | RU |
1708283 | Jan 1992 | SU |
WO 9703587 | Feb 1997 | WO |
WO 9805241 | Feb 1998 | WO |
WO 9808458 | Mar 1998 | WO |
WO 9809573 | Mar 1998 | WO |
WO 9901054 | Jan 1999 | WO |
WO 9907251 | Feb 1999 | WO |
WO 9949754 | Oct 1999 | WO |
WO 0053054 | Sep 2000 | WO |
WO 0064307 | Nov 2000 | WO |
WO 0117433 | Mar 2001 | WO |
WO 0145573 | Jun 2001 | WO |
WO 02062174 | Aug 2002 | WO |
WO 02071967 | Sep 2002 | WO |
WO 03030680 | Apr 2003 | WO |
WO 03030880 | Apr 2003 | WO |
WO 2004019801 | Mar 2004 | WO |
WO 2004026162 | Apr 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20130326831 A1 | Dec 2013 | US |
Number | Date | Country | |
---|---|---|---|
60414117 | Sep 2002 | US | |
60418776 | Oct 2002 | US | |
60419425 | Oct 2002 | US | |
60412290 | Sep 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11566479 | Dec 2006 | US |
Child | 11932010 | US | |
Parent | 10869922 | Jun 2004 | US |
Child | 11566479 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13116735 | May 2011 | US |
Child | 13965693 | US | |
Parent | 11932010 | Oct 2007 | US |
Child | 13116735 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10601106 | Jun 2003 | US |
Child | 10869922 | US | |
Parent | PCT/US03/30633 | Sep 2003 | US |
Child | 10601106 | US | |
Parent | PCT/US03/29497 | Sep 2003 | US |
Child | PCT/US03/30633 | US | |
Parent | 29189729 | Sep 2003 | US |
Child | PCT/US03/29497 | US |